The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
100 jobs Number of planned job losses
Announcement Date
10 March 2017
Employment effect (start)
10 March 2017
Foreseen end date
Description
German pharmaceutical company Ratiopharm will cut over 100 jobs at its site in Ulm. The company currently employs around 2,500 staff at its location in Ulm. Already in 2016, 100 jobs were cut at this site (see Ratiopharm 2016). Teva Deutschland, Ratiopharm's parent company, wants to restructure its business in Ulm in order o become a biotech and technology competence centre. The recently announced job cuts are to be realised by early retirement programmes and voluntary leave. However, dismissal due to operational reasons were not excluded by the management. Information on the timeline of the restructuring is yet to become available.
Ratiopharm is a German pharmaceutical company with headquarters in Ulm. The company was taken over by Teva in October 2010.
Sources
10 March 2017: Stuttgarter Zeitung
Citation
Eurofound (2017), Ratiopharm, Internal restructuring in Germany, factsheet number 90574, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/90574.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
